chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Drug interaction, Drug-genetic interaction, General physical health deterioration
Clinical narrative: my health significant damage. My health feel the evening of the second shot; There were no warnings for anyone on genetic therapy not to take it./It was not safe./ There were no warnings as to the contents nor interaction with other drugs; There were no warnings for anyone on genetic therapy not to take it./It was not safe./ There were no warnings as to the contents nor interaction with other drugs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:  The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for Covid-19 immunization.  The following information was reported: GENERAL PHYSICAL HEALTH DETERIORATION (non-serious), outcome "unknown", described as "my health significant damage. My health feel the evening of the second shot"; DRUG-GENETIC INTERACTION (non-serious), DRUG INTERACTION (non-serious), outcome "unknown" and all described as "There were no warnings for anyone on genetic therapy not to take it./It was not safe./ There were no warnings as to the contents nor interaction with other drugs".  Additional information: The patient reported that Pfizer vaccine had caused patient health significant damage. Patient health feel the evening of the second shot. There were no warnings for anyone on genetic therapy not to take it. Patient was advised by the doctor that it was safe. It was not safe. There were no warnings as to the contents nor interaction with other drugs. This activity is tantamount to genocide and you are directly responsible.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Nasopharyngitis, SARS-CoV-2 test, Vaccination failure
Clinical narrative: head cold; tested positive (rapid) for covid Saturday; tested positive (rapid) for covid Saturday; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 42-year-old male patient received BNT162b2 (BNT162B2), on 05Mar2021 at 11:00 as dose 1, single (Lot number: EN6199), in left arm, on 26Mar2021 at 10:00 as dose 2, single (Lot number: EN6855), in left arm and on 17Aug2021 at 15:00 as dose 3 (booster), single (Lot number: EW0178) at the age of 41 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ALLOPURINOL, start date: Jul2014; OMEGA 3 [FISH OIL], start date: Jan2021; TYLENOL ARTHRITIS, start date: Jan2021.  The following information was reported: COVID-19 (medically significant), VACCINATION FAILURE (medically significant) all with onset 16Apr2022, outcome "not recovered" and all described as "tested positive (rapid) for covid Saturday"; NASOPHARYNGITIS (non-serious) with onset 27Apr2022, outcome "not recovered", described as "head cold". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Apr2022) positive; (16Apr2022) Positive; (24Apr2022) Negative; (25Apr2022) Negative; (Apr2022) Positive. Therapeutic measures were taken as a result of covid-19, nasopharyngitis. The patient tested positive (rapid) for covid on Saturday 16Apr2022 and the patient received treatment with anti viral Paxlovid from 16Apr2022 to 20Apr2022 for covid-19. And tested negative (rapid) the following Sunday 24Apr2022 and again on the Monday 25Apr2022. Symptoms having largely disappeared. Then developed head cold after 2 days on 27Apr2022 and now test positive for Covid (rapid & pcr). The patient received treatment with sudafed / Tylenol. No Known allergies.
Age: 0.75
Sex: M
Vaccine: TYP
Symptoms: Incorrect route of product administration, Wrong product administered
Clinical narrative: accidentally given typhim vi instead of ipol with no reported adverse event; vaccine was also administered subcutaneously instead of intramuscularly as it was thought they are administering ipol with no reported adverse event; Initial information received on 26-Apr-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 9 months old male patient who was accidentally given typhim vi instead of ipol with and vaccine was also administered subcutaneously instead of intramuscularly as it was thought they are administering ipol with no reported adverse event while receiving vaccine typhoid vi polysaccharide vaccine [Typhim VI].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (Daptacel), hib vaccine conj (tet tox) (Acthib), pneumococcal vaccine conj 13v (crm197) (Prevnar 13) and influenza vaccine inact split 3v (Fluarix) for Prophylactic vaccination.  On 25-Apr-2022, the patient received 0.5ml once dose of suspect typhoid vi polysaccharide vaccine (strength, formulation was unknown, lot T1E142M and expiry date: 03-Sep-2022) via subcutaneous route in unknown administration site for Immunization.  On 25-Apr-2022, (Latency: same day) the patient was accidentally given typhim vi instead of ipol and administered subcutaneously instead of intramuscularly as it was thought they are administering ipol with no reported adverse event (wrong product administered, incorrect route of product administration).   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events   Outcome: Unknown  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: use past expiration date with no reported adverse event; Initial information received on 27-Apr-2022 regarding an unsolicited valid non-serious case received from a other health professional via call canter.  This case involves a 4 years old female patient who was administered with vaccine diphtheria-15/tetanus/5 ac pertussis vaccine [Daptacel] which was past expiration date with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 26-Apr-2022, the patient received a 2nd dose 0.5 ml of suspect diphtheria-15/tetanus/5 ac pertussis vaccine (strength and formulation unknown) lot C5732AA, expiry date: 22-Apr-2022, frequency: once, via intramuscular route in the left deltoid for immunization.  On 26-APR-2022, the patient developed a non-serious event use past expiration date with no reported adverse event (expired product administered) (latency same day) following the administration of diphtheria-15/tetanus/5 ac pertussis vaccine.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (expired product administered).  At time of reporting, the outcome was Unknown for the event expired product administered.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.0
Sex: M
Vaccine: DTAPIPVHIB, PPV
Symptoms: Extra dose administered, Medication error
Clinical narrative: child received an extra dose of pentacle with no reported adverse event; Initial information received on 27-Apr-2022 regarding an unsolicited valid non-serious case received from a healthcare professional.  This case involves a 1-year-old male patient who received an extra dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] with no reported adverse event.  The patient's past vaccination(s) included IPV on 21-Apr-2021, HIB VACCINE on 22-Nov-2021, DTAP VACCINE on 22-Nov-2021. The patient's past medical history, medical treatment(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ (PNEUMOCOCCAL CONJUGATE VACCINE) for Prophylactic vaccination.  On 26-Apr-2022, the patient received 0.5ml total dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (strength, formulation: unknown) (lot: UJ622AA and Expiration Date: 07-Dec-2022) via intramuscular route in the left thigh for Immunization.  On 26-Apr-2022 the patient developed a non-serious event; child received an extra dose of pentacle with no reported adverse event (extra dose administered) same day following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE.  Reportedly, Additional Description of event Adverse events: HCP states a patient was given a 5th dose of Pentacel.  Action taken with DIPHTHERIA, TETANUS, AC PERTUSSIS, IPV AND HIB VACCINE (PENTACEL) was not applicable.  It was not reported if the patient received a corrective treatment for the event (child received an extra dose of pentacle with no reported adverse event).  At time of reporting, the outcome was Unknown for the event child received an extra dose of pentacle with no reported adverse event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 18.0
Sex: M
Vaccine: HIBV
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: one patient received ACT-HIB after the diluent had expired with no adverse event; administering to a patient who is outside the approved ages of 2 months through 5 years with no adverse event; Initial information received on 27-Apr-2022 regarding an unsolicited valid  non-serious case received from from a other health professional.  This case involves a 18 years old male patient who received act-hib after the diluent had expired with no adverse event and administering to a patient who is outside the approved ages of 2 months through 5 years with no adverse event ,while receiving vaccine Hib (Prp/T) Vaccine [Act-Hib].  The patient's past medical history included Bone marrow transplant. The patient's past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Diphtheria Vaccine Toxoid, Pertussis Vaccine Acellular, Tetanus Vaccine Toxoid (Tdap); Hepatitis B Vaccine (Hepatitis B Vaccine); Pneumococcal Vaccine Conj (Pneumococcal Conjugate Vaccine); and Polio Vaccine (Polio).  On 04-Apr-2022, the patient received a  dose of suspect Hib (Prp/T) Vaccine Powder and solvent for solution for injection( lot U6901AA and UJ423AA , expiration date: 07-Mar-2022 and 20-May-2022) at a  dose of 0.25ml via intramuscular route in the right deltoid as prophylactic vaccination.  On 04-APR-2022(latency: same day),  the patient received act-hib after the diluent had expired with no adverse event (expired product administered) and administered vaccine who is outside the approved ages of 2 months through 5 years with no adverse event (Product use issue).   Action taken:  not applicable.  It was not reported if the patient received a corrective treatment for the events .   At time of reporting, the outcome was Unknown for both events   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Dizziness, Headache, Heart rate irregular, Hypertension
Clinical narrative: Unbearable headaches, sudden onset stage 3 hypertension (BP 250/146), brain aneurysm, stroke, Deterioration of vision, dizziness, seizures and irregular heartbeat
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Intracranial aneurysm, Seizure, Visual impairment
Clinical narrative: Unbearable headaches, sudden onset stage 3 hypertension (BP 250/146), brain aneurysm, stroke, Deterioration of vision, dizziness, seizures and irregular heartbeat
Age: 51.0
Sex: F
Vaccine: COVID19, VARZOS
Symptoms: Chills, Nausea, Pyrexia, Rash
Clinical narrative: Nausea, Fever (up to 101.6), chills, rash developing next day over neck, arms, back
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness
Clinical narrative: less than five minutes after administration while seated in the waiting room pt lost consciousness and was placed on the floor.  Staff called 911 instantly and EMSA arrived <60 seconds.   Pt stabilized and exited building into EMSA truck on his own feet.  EMSA reports that pt was not transferred via EMSA from pharmacy.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too Low-
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac disorder, Cardiac monitoring, Discomfort, Electrocardiogram abnormal
Clinical narrative: Injection given Wednesday 4/27/22. Thursday 4/28/22 light flu type symptoms. Body ache all over. Spent most of day sleeping or resting took tylenol for discomfort . Friday 4/29/22 3:45 AM felt heart issue. Checked twice with Watch EKG. Indicated Atrial fibrillation. Drove to hospital, EKG confirmed Atrial Fibrillation. Received two medications, heart rhythm returned to normal. Sent home with heart monitor.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pain, Somnolence
Clinical narrative: Injection given Wednesday 4/27/22. Thursday 4/28/22 light flu type symptoms. Body ache all over. Spent most of day sleeping or resting took tylenol for discomfort . Friday 4/29/22 3:45 AM felt heart issue. Checked twice with Watch EKG. Indicated Atrial fibrillation. Drove to hospital, EKG confirmed Atrial Fibrillation. Received two medications, heart rhythm returned to normal. Sent home with heart monitor.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site extravasation
Clinical narrative: Error: Leaking from Injection Site-
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Joint injury, Limb injury, Pain, Paraesthesia
Clinical narrative: Site: Pain at Injection Site-Severe, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lethargy
Clinical narrative: Systemic: Chills-Medium, Systemic: Exhaustion/Lethargy-Severe, Systemic: Headache-Medium.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Condition aggravated, Fatigue, Herpes zoster, Hypersomnia
Clinical narrative: Within two weeks of this vaccination (my third COVID vaccine, a full-dose Moderna when first two were Pfizer), my fatigue increased and amount of sleep needed to feel at all rested increased. The result has been that I can't stay awake more than 12 hours and then need to sleep equal number of hours as I was awake (so I sleep 12 hours if I was awake 12 hours). I have not recovered from this.   Last year, after my second dose of Pfizer, I had a similar adverse event that has not ended, in that I needed nap for 2-4 hours after being awake 12 hours, when previous to that time I did not need to nap after being awake 12 hours.  Therefore, the current result is that with the series of COVID vaccinations my fatigue has greatly increased and my stamina and energy have decreased; and I need much more sleep than before these vaccinations. Note I have chronic fatigue syndrome (have had it since 1994) and am very aware of my energy levels and fatigue levels, and my sleep needs. I am already on permanent disability through the Administration, prior to these adverse events.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Cough, Dizziness
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 04/23/2021.  2nd vaccine on 05/14/2021 and 3rd vaccine on 01/26/2022.  75 y/o male with PMHx of HTN, Gout, CAD, AFib, Hypothyroidism, Pituitary adenoma s/p craniotomy 3/5/2022 and adrenal insufficiency presents to ED with 1 day history of dizziness, nausea, cough, congestion, weakness and fevers.  Temp 101.6, room air sat 96% and CXR with no acute findings.  Pt did require O2 at 2L NC for a time.  Treated with IV ABX, steroids and Remdesivir.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 04/23/2021.  2nd vaccine on 05/14/2021 and 3rd vaccine on 01/26/2022.  75 y/o male with PMHx of HTN, Gout, CAD, AFib, Hypothyroidism, Pituitary adenoma s/p craniotomy 3/5/2022 and adrenal insufficiency presents to ED with 1 day history of dizziness, nausea, cough, congestion, weakness and fevers.  Temp 101.6, room air sat 96% and CXR with no acute findings.  Pt did require O2 at 2L NC for a time.  Treated with IV ABX, steroids and Remdesivir.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Syncope
Clinical narrative: Positive COVID-19 and syncope.
Age: 23.0
Sex: F
Vaccine: TD
Symptoms: Bursitis, Musculoskeletal discomfort, Shoulder injury related to vaccine administration
Clinical narrative: SIRVA, specifically bursitis. Have been taking various anti-inflammatories and resting affected shoulder.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone, Full blood count, Laboratory test, Pruritus, Rash erythematous
Clinical narrative: Since 29 December he has complained of recurrent episodes of generalized itching and rashes described as raised, red, itchy whelts which can occur anywhere on his body, especially at sites of pressure or where his skin is scraped or scratched. Lesions last less than 24 hours, affect his palms and soles, and resolve without post-inflammatory changes. He denies laryngeal, pulmonary, GI, neurologic, and cardiovascular symptoms with these episodes. Episodes not associated with heat, exercise, sweating, cold, foods, medications, NSAIDs, IV contrast, latex exposure, infections, or insect bites/stings. He received his Moderna COVID-19 vaccine booster dose on 17 December, 12 days prior to onset of symptoms. He has used oral antihistamines with benefit. He denies constitutional symptoms. UCT score today is 19 (0, 3, 1, 4, 4, 4, 1, 2). No history of adverse reactions to prior vaccines.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Rash papular, Sensitive skin, Skin lesion, Urticaria, Vitamin D decreased
Clinical narrative: Since 29 December he has complained of recurrent episodes of generalized itching and rashes described as raised, red, itchy whelts which can occur anywhere on his body, especially at sites of pressure or where his skin is scraped or scratched. Lesions last less than 24 hours, affect his palms and soles, and resolve without post-inflammatory changes. He denies laryngeal, pulmonary, GI, neurologic, and cardiovascular symptoms with these episodes. Episodes not associated with heat, exercise, sweating, cold, foods, medications, NSAIDs, IV contrast, latex exposure, infections, or insect bites/stings. He received his Moderna COVID-19 vaccine booster dose on 17 December, 12 days prior to onset of symptoms. He has used oral antihistamines with benefit. He denies constitutional symptoms. UCT score today is 19 (0, 3, 1, 4, 4, 4, 1, 2). No history of adverse reactions to prior vaccines.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer 5/19/21, 6/10/21. Positive on 5/3/22
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Heart rate increased, Injection site pain, Menstrual disorder
Clinical narrative: Fatigue- 72+ hours Injection sight soreness - 7 days Chills- 16+ hours Elevated heart rate - 95-110 bpm 12+hours starting around 9pm (normal sleep 65-68bpm) Late menstral cycle - 3 days late for first 2 cycles, change in bleeding for all cycles since vaccination  (7 cycles),  harsh cramps at end/day after period ends,
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Fatigue- 72+ hours Injection sight soreness - 7 days Chills- 16+ hours Elevated heart rate - 95-110 bpm 12+hours starting around 9pm (normal sleep 65-68bpm) Late menstral cycle - 3 days late for first 2 cycles, change in bleeding for all cycles since vaccination  (7 cycles),  harsh cramps at end/day after period ends,
Age: 66.0
Sex: U
Vaccine: PNC20
Symptoms: Pain, Product administered at inappropriate site, Shoulder injury related to vaccine administration
Clinical narrative: pt reports SIRVA, states the RX intern gave shot too high and she has had pain since shot. She reports she still has pain 1w after ortho visits scheduled.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: The vaccine administration done 13 days after the beyond-use-date (BUD). Once received, vaccines must be stored refrigerated for up to 10 weeks. These vaccines were received on January 26, 2022. The BUD was April 5, 2022. Upon receipt, the staff confused the date and documented the BUD as May 4, 2022.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Basal cell carcinoma, Biopsy larynx abnormal, Biopsy skin abnormal, Computerised tomogram neck, Endoscopy abnormal
Clinical narrative: Patient has no history of cancer, one month after vaccination, he developed  squamous cell carcinoma skin cancer as well as a basal cell carcinoma skin cancer. Three weeks after his second vaccination, he developed a persistent sore throat which never improved. Upon endoscopy, tissue changes were seen on surface of epiglottis, which with biopsy revealed Squamous Cell Carcinoma.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Epiglottic cancer, Laryngoscopy, Oropharyngeal pain, Positron emission tomogram, Squamous cell carcinoma of skin
Clinical narrative: Patient has no history of cancer, one month after vaccination, he developed  squamous cell carcinoma skin cancer as well as a basal cell carcinoma skin cancer. Three weeks after his second vaccination, he developed a persistent sore throat which never improved. Upon endoscopy, tissue changes were seen on surface of epiglottis, which with biopsy revealed Squamous Cell Carcinoma.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram normal, Epstein-Barr virus test negative, Full blood count normal, Headache, Influenza virus test negative
Clinical narrative: Developed a headache evening 2/8/2022 and not subsided since as of today 5/4/2022, neurologist diagnosed patient with NDPH 3/24/2022
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test normal, New daily persistent headache, Streptococcus test negative
Clinical narrative: Developed a headache evening 2/8/2022 and not subsided since as of today 5/4/2022, neurologist diagnosed patient with NDPH 3/24/2022
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Cough, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I started getting symptoms of scratchy throat that I thought was allergies. Then the next day I still had a scratchy throat. I took an at home COVID-19 test that was negative. I then developed a cough and could not stop coughing. That night I got a fever and was achy. I took another COVID-19 test that was positive. I still had fever, cough, and aches. I did lose my voice some as well. I called my doctor but haven't had a call back yet.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: I started getting symptoms of scratchy throat that I thought was allergies. Then the next day I still had a scratchy throat. I took an at home COVID-19 test that was negative. I then developed a cough and could not stop coughing. That night I got a fever and was achy. I took another COVID-19 test that was positive. I still had fever, cough, and aches. I did lose my voice some as well. I called my doctor but haven't had a call back yet.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain, Pain, Pyrexia, Rhinorrhoea
Clinical narrative: Approximately 2 weeks after my 2nd booster shot (Dose 4) I experienced the following symptoms: Runny nose, sore throat, coughing, body aches, low grade fever. I took Tylenol and ibuprofen. As of today I have not recovered from the symptoms and it's been ongoing ever since.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Approximately 2 weeks after my 2nd booster shot (Dose 4) I experienced the following symptoms: Runny nose, sore throat, coughing, body aches, low grade fever. I took Tylenol and ibuprofen. As of today I have not recovered from the symptoms and it's been ongoing ever since.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Heavy menstrual bleeding, Myalgia, Oligomenorrhoea, Pyrexia
Clinical narrative: Fever, aching muscles, and menstrual cycle became more extended and heavy flow.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan
Clinical narrative: Fever, aching muscles, and menstrual cycle became more extended and heavy flow.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphonia, Vocal cord paralysis
Clinical narrative: several days after 1st injection, patient developed hoarseness of voice that continued to worsen. Seen in clinic has paralysis of true vocal cord.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Malaise, Migraine
Clinical narrative: Migraine/headache for 3 days. Dull, mild headache has continued - on day 6 chills, exhaustion, overall sick feeling 2 days.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dizziness, Endodontic procedure, Fatigue, Feeling abnormal
Clinical narrative: I had got COVID-19 started feeling bad 4/6/22 but I also had a root canal, so I thought that's why I felt bad. By Saturday and Sunday, I couldn't get out of bed, really bad congestion, sore throat, tired, achy. It felt like a really bad flu I was in bed from Saturday through Monday and wasn't able to work until Tuesday. I had dizzy spells but didn't lose my sense of smell.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Influenza like illness, Mobility decreased, Oropharyngeal pain, Pain
Clinical narrative: I had got COVID-19 started feeling bad 4/6/22 but I also had a root canal, so I thought that's why I felt bad. By Saturday and Sunday, I couldn't get out of bed, really bad congestion, sore throat, tired, achy. It felt like a really bad flu I was in bed from Saturday through Monday and wasn't able to work until Tuesday. I had dizzy spells but didn't lose my sense of smell.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I had got COVID-19 started feeling bad 4/6/22 but I also had a root canal, so I thought that's why I felt bad. By Saturday and Sunday, I couldn't get out of bed, really bad congestion, sore throat, tired, achy. It felt like a really bad flu I was in bed from Saturday through Monday and wasn't able to work until Tuesday. I had dizzy spells but didn't lose my sense of smell.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Angiopathy, Arterial compression therapy, Arterial disorder, Arteriogram coronary abnormal, Arteriosclerosis coronary artery
Clinical narrative: Patient is a 80 y.o. y.o. female presenting with vomiting.  Fell one week ago with bruise on forehead.  Fell twice on weekend without injury.  4 days ago had 2nd covid booster.  Did not have vomiting side effect with prior shots.  2 days ago started vomiting continuously.  Initially food then yellow bile.  Has been unable to take meds for 2 days including diltiazem and eliquis.  Husband had bronchitis a couple of weeks ago but no GI illness.  Ate the same food as husband.  She does take an H2 blocker for stomach acid.  Has had 7 BMs in same time period but doesn't think they have been loose.  At 1030pm had last vomit and BM episode.  Felt burning chest pain after she vomited, radiated sharply to back, better now.  Called 911 for fast heartrate.  Had HR 150s-180s by paramedics.  SBP 70s.  Tried to cardiovert her twice without success.  In ER finishing 2nd liter bolus with SBP 70s on diltiazem 2.5mg/hour infusion.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Back pain, Blood loss assessment, Bundle branch block right, Cardiomegaly
Clinical narrative: Patient is a 80 y.o. y.o. female presenting with vomiting.  Fell one week ago with bruise on forehead.  Fell twice on weekend without injury.  4 days ago had 2nd covid booster.  Did not have vomiting side effect with prior shots.  2 days ago started vomiting continuously.  Initially food then yellow bile.  Has been unable to take meds for 2 days including diltiazem and eliquis.  Husband had bronchitis a couple of weeks ago but no GI illness.  Ate the same food as husband.  She does take an H2 blocker for stomach acid.  Has had 7 BMs in same time period but doesn't think they have been loose.  At 1030pm had last vomit and BM episode.  Felt burning chest pain after she vomited, radiated sharply to back, better now.  Called 911 for fast heartrate.  Had HR 150s-180s by paramedics.  SBP 70s.  Tried to cardiovert her twice without success.  In ER finishing 2nd liter bolus with SBP 70s on diltiazem 2.5mg/hour infusion.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Cardioversion, Catheterisation cardiac abnormal, Chest X-ray abnormal, Chest pain, Computerised tomogram head normal
Clinical narrative: Patient is a 80 y.o. y.o. female presenting with vomiting.  Fell one week ago with bruise on forehead.  Fell twice on weekend without injury.  4 days ago had 2nd covid booster.  Did not have vomiting side effect with prior shots.  2 days ago started vomiting continuously.  Initially food then yellow bile.  Has been unable to take meds for 2 days including diltiazem and eliquis.  Husband had bronchitis a couple of weeks ago but no GI illness.  Ate the same food as husband.  She does take an H2 blocker for stomach acid.  Has had 7 BMs in same time period but doesn't think they have been loose.  At 1030pm had last vomit and BM episode.  Felt burning chest pain after she vomited, radiated sharply to back, better now.  Called 911 for fast heartrate.  Had HR 150s-180s by paramedics.  SBP 70s.  Tried to cardiovert her twice without success.  In ER finishing 2nd liter bolus with SBP 70s on diltiazem 2.5mg/hour infusion.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Coronary artery disease, Coronary ostial stenosis, Electrocardiogram abnormal, Heart rate increased, Intensive care
Clinical narrative: Patient is a 80 y.o. y.o. female presenting with vomiting.  Fell one week ago with bruise on forehead.  Fell twice on weekend without injury.  4 days ago had 2nd covid booster.  Did not have vomiting side effect with prior shots.  2 days ago started vomiting continuously.  Initially food then yellow bile.  Has been unable to take meds for 2 days including diltiazem and eliquis.  Husband had bronchitis a couple of weeks ago but no GI illness.  Ate the same food as husband.  She does take an H2 blocker for stomach acid.  Has had 7 BMs in same time period but doesn't think they have been loose.  At 1030pm had last vomit and BM episode.  Felt burning chest pain after she vomited, radiated sharply to back, better now.  Called 911 for fast heartrate.  Had HR 150s-180s by paramedics.  SBP 70s.  Tried to cardiovert her twice without success.  In ER finishing 2nd liter bolus with SBP 70s on diltiazem 2.5mg/hour infusion.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vomiting
Clinical narrative: Patient is a 80 y.o. y.o. female presenting with vomiting.  Fell one week ago with bruise on forehead.  Fell twice on weekend without injury.  4 days ago had 2nd covid booster.  Did not have vomiting side effect with prior shots.  2 days ago started vomiting continuously.  Initially food then yellow bile.  Has been unable to take meds for 2 days including diltiazem and eliquis.  Husband had bronchitis a couple of weeks ago but no GI illness.  Ate the same food as husband.  She does take an H2 blocker for stomach acid.  Has had 7 BMs in same time period but doesn't think they have been loose.  At 1030pm had last vomit and BM episode.  Felt burning chest pain after she vomited, radiated sharply to back, better now.  Called 911 for fast heartrate.  Had HR 150s-180s by paramedics.  SBP 70s.  Tried to cardiovert her twice without success.  In ER finishing 2nd liter bolus with SBP 70s on diltiazem 2.5mg/hour infusion.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Jannsen vaccine was requested by mother for her daughter age 15. Pharmacy student did not verify patient age and administered vaccine
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pulmonary thrombosis, Thrombosis
Clinical narrative: Extensive leg clots, excessive blood clots in both lungs
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: The vaccine administration done 13 days after the beyond-use-date (BUD). Once received, vaccines must be stored refrigerated for up to 10 weeks. These vaccines were received on January 26, 2022. The BUD was April 5, 2022. Upon receipt, the staff confused the date and documented the BUD as May 4, 2022.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Influenza virus test, Respiratory syncytial virus test, SARS-CoV-2 test positive
Clinical narrative: Breakthrough COVID infection resulting in hospitalization. Symptoms are shortness of breath beginning around 4/18/22.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID infection resulting in hospitalization. Symptoms are shortness of breath beginning around 4/18/22.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Back disorder, Blood test, Dyschezia, Dysuria, Feeling cold
Clinical narrative: On 10-29-2021, in the afternoon after my 2nd Moderna dose, my feet got numb, it feels like I have heavy wrinkled socks on the bottom of both feet, whether I walk or lie down with no shoes, my feet are very cold to this day. It is more on the right leg. It starts at my waist and goes down. I was having a problem going to the bathroom.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Laboratory test, Limb discomfort, Magnetic resonance imaging abnormal
Clinical narrative: On 10-29-2021, in the afternoon after my 2nd Moderna dose, my feet got numb, it feels like I have heavy wrinkled socks on the bottom of both feet, whether I walk or lie down with no shoes, my feet are very cold to this day. It is more on the right leg. It starts at my waist and goes down. I was having a problem going to the bathroom.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: THE VACCINE ADMINISTRATION WAS DONE 13 DAYS AFTER THE BEYOND USE DATE (BUD). ONCE RECEIVED, VACCINES MUST BE STORED REFRIGERATED FOR UP TO 10 WEEKS. THESE VACCINES WERE RECEIVED ON JANUARY 26, 2022 AND THE BUD WAS APRIL 5, 2022. HOWEVER, UPON RECEIPT THE STAFF CONFUSED THE DATE AND DOCUMENTED THE BUD AS MAY 4, 2022.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Mechanical urticaria
Clinical narrative: Dermatographic urticaria
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Breast tenderness, Eye swelling, Lymphadenopathy
Clinical narrative: I had filler injections in my whole face in June 2021. This Injection  has given me  swelling under my right eye.  My prior injections gave me no adverse reactions to my face. Also, I have swollen lymph nodes under my right arm and my right breast is tender.  Not worried about the lymph nodes as this happened after the first booster shot. I am concerned about the swelling under my eye. Will take Benadryl and call Dr.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Feeling cold, Tinnitus
Clinical narrative: Pt states that 36 hrs after receiving her Pfizer COVID booster, she felt cold, weak, and had tinnitus.  The cold and weakness lasted for 3 days. The tinnitus remains.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Skin rash on torso, beginning within 12 hours, lasting 3-4 days.
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: patient given adult dose instead of pediatric - patient had no issues/reactions to dose.
Age: 27.0
Sex: M
Vaccine: HEP
Symptoms: Injected limb mobility decreased, Injection site reaction
Clinical narrative: A few hours after receiving the vaccine the employee had limited range of motion in the left arm.  Range of motion improved a few weeks later but not at 100%.  The employee says if he moves his arm a certain way, he feels some tension at the injection site.  On today, there is no swelling, redness or tenderness noted at the injection site.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dizziness, Malaise, Mobility decreased, Vertigo
Clinical narrative: Received my 4th Moderna shot on Mon. May 2, 2022 at 5:20pm. The next day, Tuesday May 3, 2022 I woke up at 9:00am and was extremely dizzy. The room felt like it was spinning. I also felt very sick in my stomach. I wasn't able to get out of bed. Finally, at 3:00pm, I started feeling better and the dizziness went away.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: 04/17/2022 tested positive for breakthrough case of COVID-19. Paxlovid was prescribed.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient given additional booster after receiving booster # 2 on 04/06/2022.  Not caught by Provider when ordering or Nurse before administering .  Patient not exhibiting any symptoms to vaccine.  had her wait the mandatory time in office to observe.  Patient advised of incident and both nurse.  Provider will reach out to patient.  Patient experienced no side effects during the wait time in office. Patient was asked for consent and no mention to getting the 4th one recently
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, COVID-19, Computerised tomogram abdomen abnormal, Death, SARS-CoV-2 test positive
Clinical narrative: Presented to ED With complaints of abdominal pain for Several days duration. He denied any hemoptysis, hematemesis or hematochezia thus presented to the ED for further evaluation.  When he arrived to the ED a CT scan of the abdomen obtained was concerning for acute ruptured appendicitis. General surgery was consulted with plans for surgical Intervention. He received IV Zosyn therapy and admitted under hospitalist service for further management.  While in hospital, patient tested positive for Covid 19 and expired on 8/24/2021.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Malaise, Oropharyngeal pain
Clinical narrative: I started getting symptoms of deep cough, chest congestion, extreme tiredness, and malaise. I had a positive COVID-19 home test on 4/26/2022. I also developed a sore throat and runny nose. I called my doctor and I also have a home health nurse and have checked my vital and was advised to rest and to take Mucinex and Tylenol. Most of the symptoms lasted for 3 days except for the sore throat and cough.